6-Bromoindirubin-3′-Oxime (BIO) enhances the transcriptional activity of β-catenin by inhibiting the activity of GSK-3β, thereby affecting multiple signaling pathways and inhibiting the proliferation, survival, and migration of tumor cells [18]. This evidence concerns the gene GSK3B and neoplasm.